Caprock Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Caprock Group's RMD Position: Q2 2026 in Review
Caprock Group increased its ResMed (RMD) stake by 1.5% in Q2 2026, buying an estimated $22.4K and bringing the position to 7,080 shares worth $1.38M. The position accounts for 0.03% of the portfolio, ranked #527.
Caprock Group first reported a position in RMD in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.97M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Caprock Group held 7,080 shares of ResMed worth $1.38M as of Q2 2026.
- Caprock Group bought 108 ResMed shares in Q2 2026, an estimated $22.4K.
- ResMed made up 0.03% of Caprock Group's portfolio in Q2 2026, its #527 holding.
- Caprock Group first reported a position in ResMed in Q4 2020 and has held it in 19 quarters since.
- Caprock Group's ResMed position peaked at $1.97M in Q3 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.